[{"address1": "2749 East Parleys Way", "address2": "Suite 200", "city": "Salt Lake City", "state": "UT", "zip": "84109", "country": "United States", "phone": "801 990 0520", "fax": "801 990 6601", "website": "https://seraprognostics.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.", "fullTimeEmployees": 55, "maxAge": 86400, "priceHint": 2, "previousClose": 7.09, "open": 7.09, "dayLow": 6.64, "dayHigh": 7.09, "regularMarketPreviousClose": 7.09, "regularMarketOpen": 7.09, "regularMarketDayLow": 6.64, "regularMarketDayHigh": 7.09, "beta": 1.179, "forwardPE": -7.0, "volume": 218399, "regularMarketVolume": 218399, "averageVolume": 162667, "averageVolume10days": 141530, "averageDailyVolume10Day": 141530, "bid": 6.62, "ask": 6.71, "bidSize": 200, "askSize": 100, "marketCap": 217147776, "fiftyTwoWeekLow": 1.52, "fiftyTwoWeekHigh": 12.355, "priceToSalesTrailing12Months": 1054.1154, "fiftyDayAverage": 9.1488, "twoHundredDayAverage": 6.15825, "currency": "USD", "enterpriseValue": 165784624, "floatShares": 18402689, "sharesOutstanding": 31686000, "sharesShort": 253476, "sharesShortPriorMonth": 234410, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0078, "heldPercentInsiders": 0.13104999, "heldPercentInstitutions": 0.67361, "shortRatio": 2.13, "shortPercentOfFloat": 0.0086, "impliedSharesOutstanding": 33341700, "bookValue": 1.988, "priceToBook": 3.3450704, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -33774000, "trailingEps": -1.07, "forwardEps": -0.95, "enterpriseToRevenue": 804.78, "enterpriseToEbitda": -4.516, "52WeekChange": 0.80706525, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "SERA", "underlyingSymbol": "SERA", "shortName": "Sera Prognostics, Inc.", "longName": "Sera Prognostics, Inc.", "firstTradeDateEpochUtc": 1626355800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ffc77ee4-8657-3dbe-b826-8ca286db1e6f", "messageBoardId": "finmb_117852744", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.65, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "totalCash": 52973000, "totalCashPerShare": 1.622, "ebitda": -36713000, "totalDebt": 1610000, "quickRatio": 2.161, "currentRatio": 2.192, "totalRevenue": 206000, "debtToEquity": 2.486, "revenuePerShare": 0.007, "returnOnAssets": -0.24034001, "returnOnEquity": -0.43591, "freeCashflow": -6627125, "operatingCashflow": -17313000, "grossMargins": 0.19903, "operatingMargins": -182.47089, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]